United States · FDA National Drug Code directory

MESALAMINE

Source ingredient · 63 source records

Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.

United States · Source reference 65649-103_5a0ee848-80a0-294e-e063-6394a90a08aa

APRISO

CAPSULE, EXTENDED RELEASE / Salix Pharmaceuticals, Inc.

United States · Source reference 58914-501_f6634219-3e94-4856-b896-67c3bd3b168d

Canasa

SUPPOSITORY / Allergan, Inc.

United States · Source reference 54092-476_405a190f-df13-4578-a988-5b291b284f21

Lialda

TABLET, DELAYED RELEASE / Takeda Pharmaceuticals America, Inc.

United States · Source reference 0527-3012_81f0e9e6-e117-46fa-b0e6-c423f63bd3d3

MESALAMINE

TABLET, DELAYED RELEASE / Lannett Company Inc.

United States · Source reference 31722-489_4597df51-7ed6-14f4-e063-6294a90afb23

MESALAMINE

CAPSULE, EXTENDED RELEASE / Camber Pharmaceuticals, Inc.

United States · Source reference 46708-724_4ef59b85-e5a5-479f-a1fe-e1cee4d87670

MESALAMINE

CAPSULE, EXTENDED RELEASE / Alembic Pharmaceuticals Limited

United States · Source reference 62332-724_7d9111a9-c8be-4823-b104-badc44eb08a5

MESALAMINE

CAPSULE, EXTENDED RELEASE / Alembic Pharmaceuticals Inc.

United States · Source reference 72162-2213_ca8d9aee-7467-4c57-8676-69293b81d7e0

MESALAMINE

TABLET, DELAYED RELEASE / Bryant Ranch Prepack

United States · Source reference 84725-002_8a38e94f-51e1-4ce1-89a4-437f7d4d5664

MESALAMINE

SUSPENSION / KLM Laboratories Private Limited

United States · Source reference 0093-5907_5c416cce-8cdd-4ce2-834d-19783189b85e

Mesalamine

CAPSULE, DELAYED RELEASE / Teva Pharmaceuticals USA, Inc.

United States · Source reference 0378-1375_20730160-16c5-4fee-90c9-9c28031ac8f8

Mesalamine

CAPSULE, EXTENDED RELEASE / Mylan Pharmaceuticals Inc.

United States · Source reference 0472-1915_380df1f0-2282-4c49-bd7c-40b244f875d4

Mesalamine

SUPPOSITORY / Actavis Pharma, Inc.

United States · Source reference 0480-7750_dcee5545-97f3-4418-87f6-5060e540342d

Mesalamine

TABLET, DELAYED RELEASE / Teva Pharmaceuticals, Inc.

United States · Source reference 0591-2245_1300887a-c110-46b3-a8be-cfceabf0cbf2

Mesalamine

TABLET, DELAYED RELEASE / Actavis Pharma, Inc.

United States · Source reference 0781-2791_52d8e30f-56bb-4822-8c6b-448ca3cd1923

Mesalamine

CAPSULE, EXTENDED RELEASE / Sandoz Inc

United States · Source reference 0781-2793_52d8e30f-56bb-4822-8c6b-448ca3cd1923

Mesalamine

CAPSULE, EXTENDED RELEASE / Sandoz Inc

United States · Source reference 0832-6056_44e0cd4f-abe7-5e61-e063-6294a90a988b

Mesalamine

CAPSULE, EXTENDED RELEASE / Upsher-Smith Laboratories, LLC

United States · Source reference 16571-246_92e26463-9c71-456e-b800-351162846b68

Mesalamine

SUPPOSITORY / Rising Pharma Holdings, Inc.

United States · Source reference 16714-245_d5210f4f-1604-4319-ad99-b44167e66c00

Mesalamine

SUPPOSITORY / Northstar Rx LLC.

United States · Source reference 21922-045_6ffc01fa-3cf5-4e6c-9760-7ff9873c82df

Mesalamine

SUSPENSION / Encube Ethicals, Inc.

United States · Source reference 31722-005_1248c2d3-b241-5551-e063-6294a90a2f4e

Mesalamine

SUPPOSITORY / Camber Pharmaceuticals, Inc.

United States · Source reference 31722-043_116b9d88-f7d4-f30e-e063-6394a90a3912

Mesalamine

TABLET, DELAYED RELEASE / Camber Pharmaceuticals, Inc.

United States · Source reference 42291-489_485f7bde-a4c9-b05b-e063-6394a90a34cf

Mesalamine

TABLET, DELAYED RELEASE / AvKARE

United States · Source reference 45802-098_f416ded9-2018-4422-8cff-c6fc563a3772

Mesalamine

ENEMA / Padagis Israel Pharmaceuticals Ltd

United States · Source reference 50268-577_2b4a9376-8515-3d10-e063-6394a90a0aad

Mesalamine

CAPSULE, EXTENDED RELEASE / AvPAK

United States · Source reference 50742-371_a250353b-8338-43bf-b451-a0e715293196

Mesalamine

CAPSULE, EXTENDED RELEASE / Ingenus Pharmaceuticals, LLC

United States · Source reference 51407-976_4c4ffb68-3c5f-35cd-e063-6294a90ab929

Mesalamine

CAPSULE, EXTENDED RELEASE / Golden State Medical Supply, Inc.

United States · Source reference 54092-100_100a57d9-5335-4dd4-86ba-4ea9a22dfc39

Mesalamine

TABLET, DELAYED RELEASE / Takeda Pharmaceuticals America, Inc.

United States · Source reference 59651-397_904a1ef1-2677-46f0-bfdb-645d1638d5dc

Mesalamine

CAPSULE, EXTENDED RELEASE / Aurobindo Pharma Limited

United States · Source reference 60687-397_278689c8-9371-59ed-e063-6294a90a7bda

Mesalamine

TABLET, DELAYED RELEASE / American Health Packaging

Browse ingredients in United States →